These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 411670

  • 1. Biocompatibility of coated and uncoated charcoal during haemoperfusion in healthy dogs.
    Weston MJ, Hanid A, Rubin MH, Langley PG, Mellon PJ, Williams R.
    Eur J Clin Invest; 1977 Oct; 7(5):401-6. PubMed ID: 411670
    [Abstract] [Full Text] [Related]

  • 2. Platelet function in fulminant hepatic failure and effect of charcoal haemoperfusion.
    Weston MJ, Langley PG, Rubin MH, Hanid MA, Mellon P, Williams R.
    Gut; 1977 Nov; 18(11):897-902. PubMed ID: 590850
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prostacyclin to prevent platelet activation during charcoal haemoperfusion in fulminant hepatic failure.
    Gimson AE, Langley PG, Hughes RD, Canalese J, Mellon PJ, Williams R, Woods HF, Weston MJ.
    Lancet; 1980 Jan 26; 1(8161):173-5. PubMed ID: 6101632
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In-vitro blood compatibility studies on a new polymer-coated charcoal for haemoperfusion.
    Hughes RD, Langley PG, Williams R.
    Int J Artif Organs; 1980 Sep 26; 3(5):277-9. PubMed ID: 7461861
    [Abstract] [Full Text] [Related]

  • 8. The use of an in vitro haemoperfusion circuit to evaluate the blood compatibility of albumin-coated Amberlite XAD-7 resin.
    Hughes RD, Ton HY, Langley PG, Silk DB, Williams R.
    Int J Artif Organs; 1978 May 26; 1(3):129-34. PubMed ID: 689755
    [Abstract] [Full Text] [Related]

  • 9. Prostacyclin eliminates the thrombocytopenia associated with charcoal hemoperfusion and minimizes heparin and fibrinogen consumption.
    Woods HF, Weston MJ, Bunting S, Moncada S, Vane J.
    Artif Organs; 1980 Aug 26; 4(3):176-9. PubMed ID: 6998437
    [Abstract] [Full Text] [Related]

  • 10. The influence of haemoperfusion on haemostasis and cellular constituents of the blood in the treatment of intoxications: a comparative study of three types of columns (Haemocol, Amberlite XAD-4, Gambro Adsorba 300 C).
    Sangster B, van Heijst AN, Sixma JJ.
    Arch Toxicol; 1981 Jul 26; 47(4):269-78. PubMed ID: 7271453
    [Abstract] [Full Text] [Related]

  • 11. Acid citrate dextrose reduces platelet retention during in vitro and in vivo dog hemoperfusion: a comparative study of different charcoal adsorbers.
    Tangerman A, Snel P, van Schaik A, van Tongeren JH.
    Artif Organs; 1981 Nov 26; 5(4):357-62. PubMed ID: 7325877
    [Abstract] [Full Text] [Related]

  • 12. The use of calcium chelating agents and prostaglandin E to eliminate platelet and white blood cell losses resulting from hemoperfusion through uncoated charcoal, albumin-agarose gel, and neutral and cation exchange resins.
    Scharschmidt BF, Martin JF, Shapiro LJ, Plotz PH, Berk PD.
    J Lab Clin Med; 1977 Jan 26; 89(1):110-9. PubMed ID: 401516
    [Abstract] [Full Text] [Related]

  • 13. Activated charcoal haemoperfusion via an extracorporeal circuit in the unrestrained and unanaesthetized rat.
    Ryan CJ, Courtney JM, Wood CB, Hood RG, Blumgart LH.
    Br J Exp Pathol; 1979 Aug 26; 60(4):400-10. PubMed ID: 508590
    [Abstract] [Full Text] [Related]

  • 14. Effect of hemoperfusion with coated and uncoated charcoal on human blood in vitro.
    Ott NT, Kohnle W, Scheck R, Konstantin P, Franz HE.
    J Dial; 1979 Aug 26; 3(4):291-308. PubMed ID: 263952
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Biocompatibility of haemoperfusion.
    Rommes JH, Sangster B, Berrens L, Borst C, van Heijst AN.
    Arch Toxicol; 1986 Feb 26; 58(3):187-95. PubMed ID: 3964083
    [Abstract] [Full Text] [Related]

  • 17. Earlier charcoal haemoperfusion in fulminant hepatic failure.
    Gimson AE, Braude S, Mellon PJ, Canalese J, Williams R.
    Lancet; 1982 Sep 25; 2(8300):681-3. PubMed ID: 6126626
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of factors affecting the formation of thrombi in hemoperfusion columns].
    Sevela K, Gajdůsková V.
    Vnitr Lek; 1996 Jun 25; 42(6):408-13. PubMed ID: 8928412
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.